South Korea Clinical Research Organisation (CRO) Market 2023 by Company, Regions, Type and Application, Forecast to 2030

Report ID: IBI1433127 | Category: Service & Software | Pages: 132 | Format: PDF | Published Date: June 20,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3550.00 Multi User-$4550.00

Report Description
View Table of Contents

Report Summary

The Clinical Research Organisation (CRO) market report provides a detailed analysis of South Korea market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and South Korea market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The South Korea Clinical Research Organisation (CRO) market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of USD  million by 2030 with a CAGR of  % during review period. Pharmaceutical Company accounting for  % of the Clinical Research Organisation (CRO) South Korea market in 2022, is projected to value USD  million by 2030, growing at a  % CAGR in next six years. While Small molecules segment is altered to a  % CAGR between 2023 and 2030.
South Korea key companies of Clinical Research Organisation (CRO) include Charles River Laboratories, IQVIA, LabCorp, Domainex, and Evotec AG, etc. In terms of revenue, the South Korea top four players hold a share over  % in 2022.
Market segmentation
Clinical Research Organisation (CRO) market is split by Type and by Application. For the period 2017-2030, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Small molecules
    Biologics
Market segment by Application, can be divided into
    Pharmaceutical Company
    Research Institute
    Other
Market segment by players, this report covers
    Charles River Laboratories
    IQVIA
    LabCorp
    Domainex
    Evotec AG
    Genscript Biotech
    GVK Biosciences
    Aurobindo Pharma
    Eurofins Scientific
    Reprocell
    Dalton Pharma
    NovAliX
    Jubilant Biosys
    Lupin Pharmaceuticals
    Piramal Pharma
    Sun Pharmaceutical
    Sai Ganga Panakeia
    Vitas Pharma
    Pharmaron Beijing
    WuXi AppTec
    Asymchem Laboratories
    Porton Pharma
    ChemPartner
    Hangzhou Tigermed
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Clinical Research Organisation (CRO) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Clinical Research Organisation (CRO), with revenue, gross margin and South Korea market share of Clinical Research Organisation (CRO) from 2017 to 2023.
Chapter 3, the Clinical Research Organisation (CRO) competitive situation, revenue and South Korea market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2023.and Clinical Research Organisation (CRO) market forecast, by regions, type and application, with revenue, from 2023 to 2030.
Chapter 11 and 12, to describe Clinical Research Organisation (CRO) research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Product Overview and Scope of Clinical Research Organisation (CRO)
    1.2 Classification of Clinical Research Organisation (CRO) by Type
        1.2.1 Overview: South Korea Clinical Research Organisation (CRO) Market Size by Type: 2017 Versus 2022 Versus 2030
        1.2.2 South Korea Clinical Research Organisation (CRO) Revenue Market Share by Type in 2022
        1.2.3 Small molecules
        1.2.4 Biologics
    1.3 South Korea Clinical Research Organisation (CRO) Market by Application
        1.3.1 Overview: South Korea Clinical Research Organisation (CRO) Market Size by Application: 2017 Versus 2022 Versus 2030
        1.3.2 Pharmaceutical Company
        1.3.3 Research Institute
        1.3.4 Other
    1.4 South Korea Clinical Research Organisation (CRO) Market Size & Forecast
    1.5 South Korea Clinical Research Organisation (CRO) Market Size and Forecast by Region
        1.5.1 South Korea Clinical Research Organisation (CRO) Market Size by Region: 2017 VS 2022 VS 2030
        1.5.2 South Korea Clinical Research Organisation (CRO) Market Size by Region, (2017-2023)
        1.5.3 North America Clinical Research Organisation (CRO) Market Size and Prospect (2017-2030)
        1.5.4 Europe Clinical Research Organisation (CRO) Market Size and Prospect (2017-2030)
        1.5.5 Asia-Pacific Clinical Research Organisation (CRO) Market Size and Prospect (2017-2030)
        1.5.6 South America Clinical Research Organisation (CRO) Market Size and Prospect (2017-2030)
        1.5.7 Middle East and Africa Clinical Research Organisation (CRO) Market Size and Prospect (2017-2030)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Clinical Research Organisation (CRO) Market Drivers
        1.6.2 Clinical Research Organisation (CRO) Market Restraints
        1.6.3 Clinical Research Organisation (CRO) Trends Analysis
2 Company Profiles
    2.1 Charles River Laboratories
        2.1.1 Charles River Laboratories Details
        2.1.2 Charles River Laboratories Major Business
        2.1.3 Charles River Laboratories Clinical Research Organisation (CRO) Product and Solutions
        2.1.4 Charles River Laboratories Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.1.5 Charles River Laboratories Recent Developments and Future Plans
    2.2 IQVIA
        2.2.1 IQVIA Details
        2.2.2 IQVIA Major Business
        2.2.3 IQVIA Clinical Research Organisation (CRO) Product and Solutions
        2.2.4 IQVIA Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.2.5 IQVIA Recent Developments and Future Plans
    2.3 LabCorp
        2.3.1 LabCorp Details
        2.3.2 LabCorp Major Business
        2.3.3 LabCorp Clinical Research Organisation (CRO) Product and Solutions
        2.3.4 LabCorp Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.3.5 LabCorp Recent Developments and Future Plans
    2.4 Domainex
        2.4.1 Domainex Details
        2.4.2 Domainex Major Business
        2.4.3 Domainex Clinical Research Organisation (CRO) Product and Solutions
        2.4.4 Domainex Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.4.5 Domainex Recent Developments and Future Plans
    2.5 Evotec AG
        2.5.1 Evotec AG Details
        2.5.2 Evotec AG Major Business
        2.5.3 Evotec AG Clinical Research Organisation (CRO) Product and Solutions
        2.5.4 Evotec AG Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.5.5 Evotec AG Recent Developments and Future Plans
    2.6 Genscript Biotech
        2.6.1 Genscript Biotech Details
        2.6.2 Genscript Biotech Major Business
        2.6.3 Genscript Biotech Clinical Research Organisation (CRO) Product and Solutions
        2.6.4 Genscript Biotech Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.6.5 Genscript Biotech Recent Developments and Future Plans
    2.7 GVK Biosciences
        2.7.1 GVK Biosciences Details
        2.7.2 GVK Biosciences Major Business
        2.7.3 GVK Biosciences Clinical Research Organisation (CRO) Product and Solutions
        2.7.4 GVK Biosciences Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.7.5 GVK Biosciences Recent Developments and Future Plans
    2.8 Aurobindo Pharma
        2.8.1 Aurobindo Pharma Details
        2.8.2 Aurobindo Pharma Major Business
        2.8.3 Aurobindo Pharma Clinical Research Organisation (CRO) Product and Solutions
        2.8.4 Aurobindo Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.8.5 Aurobindo Pharma Recent Developments and Future Plans
    2.9 Eurofins Scientific
        2.9.1 Eurofins Scientific Details
        2.9.2 Eurofins Scientific Major Business
        2.9.3 Eurofins Scientific Clinical Research Organisation (CRO) Product and Solutions
        2.9.4 Eurofins Scientific Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.9.5 Eurofins Scientific Recent Developments and Future Plans
    2.10 Reprocell 
        2.10.1 Reprocell Details
        2.10.2 Reprocell Major Business
        2.10.3 Reprocell Clinical Research Organisation (CRO) Product and Solutions
        2.10.4 Reprocell Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.10.5 Reprocell Recent Developments and Future Plans
    2.11 Dalton Pharma
        2.11.1 Dalton Pharma Details
        2.11.2 Dalton Pharma Major Business
        2.11.3 Dalton Pharma Clinical Research Organisation (CRO) Product and Solutions
        2.11.4 Dalton Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.11.5 Dalton Pharma Recent Developments and Future Plans
    2.12 NovAliX
        2.12.1 NovAliX Details
        2.12.2 NovAliX Major Business
        2.12.3 NovAliX Clinical Research Organisation (CRO) Product and Solutions
        2.12.4 NovAliX Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.12.5 NovAliX Recent Developments and Future Plans
    2.13 Jubilant Biosys
        2.13.1 Jubilant Biosys Details
        2.13.2 Jubilant Biosys Major Business
        2.13.3 Jubilant Biosys Clinical Research Organisation (CRO) Product and Solutions
        2.13.4 Jubilant Biosys Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.13.5 Jubilant Biosys Recent Developments and Future Plans
    2.14 Lupin Pharmaceuticals
        2.14.1 Lupin Pharmaceuticals Details
        2.14.2 Lupin Pharmaceuticals Major Business
        2.14.3 Lupin Pharmaceuticals Clinical Research Organisation (CRO) Product and Solutions
        2.14.4 Lupin Pharmaceuticals Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.14.5 Lupin Pharmaceuticals Recent Developments and Future Plans
    2.15 Piramal Pharma
        2.15.1 Piramal Pharma Details
        2.15.2 Piramal Pharma Major Business
        2.15.3 Piramal Pharma Clinical Research Organisation (CRO) Product and Solutions
        2.15.4 Piramal Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.15.5 Piramal Pharma Recent Developments and Future Plans
    2.16 Sun Pharmaceutical
        2.16.1 Sun Pharmaceutical Details
        2.16.2 Sun Pharmaceutical Major Business
        2.16.3 Sun Pharmaceutical Clinical Research Organisation (CRO) Product and Solutions
        2.16.4 Sun Pharmaceutical Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.16.5 Sun Pharmaceutical Recent Developments and Future Plans
    2.17 Sai Ganga Panakeia
        2.17.1 Sai Ganga Panakeia Details
        2.17.2 Sai Ganga Panakeia Major Business
        2.17.3 Sai Ganga Panakeia Clinical Research Organisation (CRO) Product and Solutions
        2.17.4 Sai Ganga Panakeia Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.17.5 Sai Ganga Panakeia Recent Developments and Future Plans
    2.18 Vitas Pharma
        2.18.1 Vitas Pharma Details
        2.18.2 Vitas Pharma Major Business
        2.18.3 Vitas Pharma Clinical Research Organisation (CRO) Product and Solutions
        2.18.4 Vitas Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.18.5 Vitas Pharma Recent Developments and Future Plans
    2.19 Pharmaron Beijing
        2.19.1 Pharmaron Beijing Details
        2.19.2 Pharmaron Beijing Major Business
        2.19.3 Pharmaron Beijing Clinical Research Organisation (CRO) Product and Solutions
        2.19.4 Pharmaron Beijing Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.19.5 Pharmaron Beijing Recent Developments and Future Plans
    2.20 WuXi AppTec
        2.20.1 WuXi AppTec Details
        2.20.2 WuXi AppTec Major Business
        2.20.3 WuXi AppTec Clinical Research Organisation (CRO) Product and Solutions
        2.20.4 WuXi AppTec Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.20.5 WuXi AppTec Recent Developments and Future Plans
    2.21 Asymchem Laboratories
        2.21.1 Asymchem Laboratories Details
        2.21.2 Asymchem Laboratories Major Business
        2.21.3 Asymchem Laboratories Clinical Research Organisation (CRO) Product and Solutions
        2.21.4 Asymchem Laboratories Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.21.5 Asymchem Laboratories Recent Developments and Future Plans
    2.22 Porton Pharma
        2.22.1 Porton Pharma Details
        2.22.2 Porton Pharma Major Business
        2.22.3 Porton Pharma Clinical Research Organisation (CRO) Product and Solutions
        2.22.4 Porton Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.22.5 Porton Pharma Recent Developments and Future Plans
    2.23 ChemPartner
        2.23.1 ChemPartner Details
        2.23.2 ChemPartner Major Business
        2.23.3 ChemPartner Clinical Research Organisation (CRO) Product and Solutions
        2.23.4 ChemPartner Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.23.5 ChemPartner Recent Developments and Future Plans
    2.24 Hangzhou Tigermed
        2.24.1 Hangzhou Tigermed Details
        2.24.2 Hangzhou Tigermed Major Business
        2.24.3 Hangzhou Tigermed Clinical Research Organisation (CRO) Product and Solutions
        2.24.4 Hangzhou Tigermed Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, 2022, and 2023)
        2.24.5 Hangzhou Tigermed Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 South Korea Clinical Research Organisation (CRO) Revenue and Share by Players (2019, 2020, 2021, 2022, and 2023)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Clinical Research Organisation (CRO) Players Market Share in 2022
        3.2.2 Top 10 Clinical Research Organisation (CRO) Players Market Share in 2022
        3.2.3 Market Competition Trend
    3.3 Clinical Research Organisation (CRO) Players Head Office, Products and Services Provided
    3.4 Clinical Research Organisation (CRO) Mergers & Acquisitions
    3.5 Clinical Research Organisation (CRO) New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 South Korea Clinical Research Organisation (CRO) Revenue and Market Share by Type (2017-2023)
    4.2 South Korea Clinical Research Organisation (CRO) Market Forecast by Type (2023-2030)
5 Market Size Segment by Application
    5.1 South Korea Clinical Research Organisation (CRO) Revenue Market Share by Application (2017-2023)
    5.2 South Korea Clinical Research Organisation (CRO) Market Forecast by Application (2023-2030)
6 North America by Country, by Type, and by Application
    6.1 North America Clinical Research Organisation (CRO) Revenue by Type (2017-2030)
    6.2 North America Clinical Research Organisation (CRO) Revenue by Application (2017-2030)
    6.3 North America Clinical Research Organisation (CRO) Market Size by Country
        6.3.1 North America Clinical Research Organisation (CRO) Revenue by Country (2017-2030)
        6.3.2 United States Clinical Research Organisation (CRO) Market Size and Forecast (2017-2030)
        6.3.3 Canada Clinical Research Organisation (CRO) Market Size and Forecast (2017-2030)
        6.3.4 Mexico Clinical Research Organisation (CRO) Market Size and Forecast (2017-2030)
7 Europe by Country, by Type, and by Application
    7.1 Europe Clinical Research Organisation (CRO) Revenue by Type (2017-2030)
    7.2 Europe Clinical Research Organisation (CRO) Revenue by Application (2017-2030)
    7.3 Europe Clinical Research Organisation (CRO) Market Size by Country
        7.3.1 Europe Clinical Research Organisation (CRO) Revenue by Country (2017-2030)
        7.3.2 Germany Clinical Research Organisation (CRO) Market Size and Forecast (2017-2030)
        7.3.3 France Clinical Research Organisation (CRO) Market Size and Forecast (2017-2030)
        7.3.4 United Kingdom Clinical Research Organisation (CRO) Market Size and Forecast (2017-2030)
        7.3.5 Russia Clinical Research Organisation (CRO) Market Size and Forecast (2017-2030)
        7.3.6 Italy Clinical Research Organisation (CRO) Market Size and Forecast (2017-2030)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Clinical Research Organisation (CRO) Revenue by Type (2017-2030)
    8.2 Asia-Pacific Clinical Research Organisation (CRO) Revenue by Application (2017-2030)
    8.3 Asia-Pacific Clinical Research Organisation (CRO) Market Size by Region
        8.3.1 Asia-Pacific Clinical Research Organisation (CRO) Revenue by Region (2017-2030)
        8.3.2 China Clinical Research Organisation (CRO) Market Size and Forecast (2017-2030)
        8.3.3 Japan Clinical Research Organisation (CRO) Market Size and Forecast (2017-2030)
        8.3.4 South Korea Clinical Research Organisation (CRO) Market Size and Forecast (2017-2030)
        8.3.5 India Clinical Research Organisation (CRO) Market Size and Forecast (2017-2030)
        8.3.6 Southeast Asia Clinical Research Organisation (CRO) Market Size and Forecast (2017-2030)
        8.3.7 Australia Clinical Research Organisation (CRO) Market Size and Forecast (2017-2030)
9 South America by Country, by Type, and by Application
    9.1 South America Clinical Research Organisation (CRO) Revenue by Type (2017-2030)
    9.2 South America Clinical Research Organisation (CRO) Revenue by Application (2017-2030)
    9.3 South America Clinical Research Organisation (CRO) Market Size by Country
        9.3.1 South America Clinical Research Organisation (CRO) Revenue by Country (2017-2030)
        9.3.2 Brazil Clinical Research Organisation (CRO) Market Size and Forecast (2017-2030)
        9.3.3 Argentina Clinical Research Organisation (CRO) Market Size and Forecast (2017-2030)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Clinical Research Organisation (CRO) Revenue by Type (2017-2030)
    10.2 Middle East & Africa Clinical Research Organisation (CRO) Revenue by Application (2017-2030)
    10.3 Middle East & Africa Clinical Research Organisation (CRO) Market Size by Country
        10.3.1 Middle East & Africa Clinical Research Organisation (CRO) Revenue by Country (2017-2030)
        10.3.2 Turkey Clinical Research Organisation (CRO) Market Size and Forecast (2017-2030)
        10.3.3 Saudi Arabia Clinical Research Organisation (CRO) Market Size and Forecast (2017-2030)
        10.3.4 UAE Clinical Research Organisation (CRO) Market Size and Forecast (2017-2030)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

South Korea Clinical Research Organisation (CRO) Market 2023 by Company, Regions, Type and Application, Forecast to 2030

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?